Whole-genome bisulfite sequencing of cell-free DNA identifies signature associated with metastatic breast cancer

BACKGROUND: A number of clinico-pathological criteria and molecular profiles have been used to stratify patients into high- and low-risk groups. Currently, there are still no effective methods to determine which patients harbor micrometastatic disease after standard breast cancer therapy and who wil...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Epigenetics
Autors principals: Legendre, Christophe, Gooden, Gerald C., Johnson, Kyle, Martinez, Rae Anne, Liang, Winnie S., Salhia, Bodour
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4573288/
https://ncbi.nlm.nih.gov/pubmed/26380585
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-015-0135-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars